Fri, Sep 25 2020

After 7 years of avoiding pancreatic enzyme replacement therapy (PERT), I finally asked for some on a trial basis. To be honest, for some time, I thought they were really only needed in the NET world for those with pancreatic issues (pNETs). I've…

PARP inhibitors are rapidly transforming the treatment of ovarian, breast, prostate and other types of cancer. To develop these drugs, researchers supported by Cancer Research UK had to decipher how blocking DNA repair could expose a weak point in…

Another day, another set of gloomy statistics. Today's new figures from the UK's National Cancer Research Institute project a devastating 24% drop in the UK's overall cancer research spending this year, driven by a 46% fall in charity sector…

The purpose of this survey is to gain insight into the patient pathway for those diagnosed with neuroendocrine cancers (NCs), including presenting symptoms, experience with referrals and investigations and interactions with primary and secondary…

Children and young people in the UK with cancers that have come back can now access new personalised treatments quicker than ever before thanks to a national tumour biopsy sequencing platform and clinical trial funded by Cancer Research UK*. The…

Before I was diagnosed with cancer, my health was in reasonable condition. I had minor irritants that seemed to come back now and then, nothing that was going to kill me. So I just put up with most of it and time was frequently a good healer.